KRISTI BOSE: Open Payments
NPI 1336680396 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 75 payments from 15 companies in 2025. Trend: 2023 $2,298 · 2024 $1,525 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $191 |
| ABBVIE INC. | 15 | $150 |
| Axsome Therapeutics, Inc. | 9 | $141 |
| Lundbeck LLC | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Alkermes, Inc. | 1 | $25 |
Products named: CAPLYTA, REXULTI, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, COBENFY, Jornay PM, FANAPT.
Industry payments across NE — which companies pay providers there.
